Stable Isotope Labelled Ralpancizumab Biosimilar – Anti-PCSK9/NARC1/ PC9 mAb – Research Grade

Reference: PX-TA1340-SIL-1MG
Size

Brand

Product type

Clonality

Expression system

Applications

Product nameStable Isotope Labelled Ralpancizumab Biosimilar - Anti-PCSK9/NARC1/ PC9 mAb - Research Grade
SourceCAS 1407495-04-8
SpeciesHumanized
Expression systemMammalian cells
Purity>95%
BufferPBS buffer PH7.5
Delivery conditionBlue Ice
Delivery Time3-5 days if in stock; 5-8 weeks if production needed
Storage conditionstore at -80°C
BrandProteoGenix
ApplicationsMS
Aliases /SynonymsPF-05335810,RN317
ReferencePX-TA1340-SIL
NoteFor research use only. Not suitable for clinical or therapeutic use.
IsotypeIgG2-kappa
ClonalityMonoclonal Antibody
FormatLyophilized
LabellingArginine: 13C6,15N4 ; Lysine: 13C6,15N2, >99%
Isotopic Enrichment99%
Stability1 year

Description of Ralpancizumab Biosimilar - Anti-PCSK9/NARC1/ PC9 mAb - Research Grade

General information on Anti-PCSK9/NARC1/ PC9[Homo sapiens] (Ralpancizumab) Monoclonal Antibody

Ralpancizumab has been investigated for the treatment of Hypercholesterolemia.

Reviews

There are no reviews yet.

REVIEW YOUR PRODUCT

Be the first to review “Stable Isotope Labelled Ralpancizumab Biosimilar – Anti-PCSK9/NARC1/ PC9 mAb – Research Grade”

Your email address will not be published. Required fields are marked *

Contact us

Send us a message from the form below







    Cart (0 Items)

    Your cart is currently empty.

    View Products